Elucigene Recognised by Innovation100 Greater Manchester

Elucigene Diagnostics are delighted to have been recognised as one of the top 100 most innovative companies in Greater Manchester, in a report produced by BQ and the Business Growth Hub, part of The Growth Company. The new initiative is designed to shine the spotlight...

MEDLAB 2017 Dubai Attendance

Elucigene Diagnostics are excited to announce that we are exhibiting at MEDLAB 2017 in Dubai from Monday 6th February to Thursday 9th February. Our Sales and Marketing Director; Mark Street Docherty and Business Development lead; Erinn Ogg, are in attendance at stand...

ESHG 2016

Elucigene Diagnostics have been exhibiting at ESHG 2016 in Barcelona this week, from Saturday 21st May to Monday 23rd May. The European Society of Human Genetics is an exciting opportunity to meet our team and learn about our new products.   Delegates Erinn Ogg,...

GfH 2016 Attendance & CF-DE Panel

Elucigene Diagnostics will be in attendance at GfH in Lübeck this week with our German partner Cytogen, and available to speak to customers regarding the new Cystic Fibrosis German panel that is under development for later this year. The national newborn CF screening...

New! FMF kit

Elucigene Diagnostics are excited to announce the release of their new assay for the determination of the carrier status of Familial Mediterranean Fever. Familial Mediterranean Fever (FMF) is an autosomal recessive disease caused by mutations within the MEFV gene. It...